Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.64 - $1.31 $3,719 - $7,613
-5,812 Reduced 35.85%
10,398 $9,000
Q3 2022

Nov 10, 2022

SELL
$0.8 - $1.65 $492 - $1,014
-615 Reduced 3.66%
16,210 $21,000
Q2 2022

Aug 15, 2022

BUY
$0.56 - $3.25 $8,727 - $50,648
15,584 Added 1255.76%
16,825 $15,000
Q1 2022

May 12, 2022

BUY
$2.46 - $5.92 $3,052 - $7,346
1,241 New
1,241 $4,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.